首页> 外文OA文献 >Response to Letter Regarding Article, “Defining Clinically Relevant Cerebral Hemorrhage After Thrombolytic Therapy for Stroke: Analysis of the National Institute of Neurological Disorders and Stroke Tissue-Type Plasminogen Activator Trials”

【2h】

Response to Letter Regarding Article, “Defining Clinically Relevant Cerebral Hemorrhage After Thrombolytic Therapy for Stroke: Analysis of the National Institute of Neurological Disorders and Stroke Tissue-Type Plasminogen Activator Trials”

机译：对文章的回应，“在中风溶栓治疗后定义临床相关的脑出血：分析了国家神经障碍研究所和中风组织型纤溶酶原试验”

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Neal Matsumori Rao; Steven R. Levine; Jeffrey L. Saver;
展开▼
作者单位

展开▼
年度 2015
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献

1. Response to Letter Regarding Article, "Defining Clinically Relevant Cerebral Hemorrhage After Thrombolytic Therapy for Stroke: Analysis of the National Institute of Neurological Disorders and Stroke Tissue-Type Plasminogen Activator Trials" [J] . Matsumori Neal, Levine Steven R., Saver Jeffrey L. Stroke: A Journal of Cerebral Circulation . 2015,第2期

机译：对关于“定义脑卒中溶栓治疗后临床相关脑出血的文章：美国国立神经疾病研究所和中风组织型纤溶酶原激活物试验的分析”一文的答复
2. Letter by Turc et al Regarding Article, "Defining Clinically Relevant Cerebral Hemorrhage After Thrombolytic Therapy for Stroke: Analysis of the National Institute of Neurological Disorders and Stroke Tissue-Type Plasminogen Activator Trials" [J] . Turc Guillaume, Tisserand Marie, Seners Pierre, Stroke: A Journal of Cerebral Circulation . 2015,第2期

机译：Turc等人关于文章的信，“定义脑卒中溶栓治疗后的临床相关性脑出血：美国国家神经疾病研究所和中风组织型纤溶酶原激活物试验的分析”
3. Defining Clinically Relevant Cerebral Hemorrhage After Thrombolytic Therapy for Stroke Analysis of the National Institute of Neurological Disorders and Stroke Tissue-Type Plasminogen Activator Trials [J] . Rao Neal M., Levine Steven R., Gornbein Jeffrey A., Stroke: A Journal of Cerebral Circulation . 2014,第9期

机译：国立神经病学会和中风组织型纤溶酶原激活物试验的中风分析的溶栓治疗后定义临床相关的脑出血
4. Response to Letter Regarding Article Targeting recombinant tissue-type plasminogen activator in acute ischemic stroke based on risk of intracranial hemorrhage or poor functional outcome: An analysis of the third international stroke trial [O] . William N. Whiteley, Douglas Thompson, Peter Sandercock -1

机译：对有关基于颅内出血或不良功能预后的风险针对急性缺血性卒中的重组组织型纤溶酶原激活物的靶向：第三项国际卒中试验的分析一文的回复
5. Letter by Turc et al Regarding Article, “Defining Clinically Relevant Cerebral Hemorrhage After Thrombolytic Therapy for Stroke: Analysis of the National Institute of Neurological Disorders and Stroke Tissue-Type Plasminogen Activator Trials” [O] . Guillaume Turc, Marie Tisserand, Pierre Seners, 2015

机译：Turc等人关于文章的信，“在中风溶栓治疗后定义临床相关的脑出血：分析国家神经障碍研究所和中风组织型纤溶酶原试验”
6. National Institute of Neurological Disorders and Stroke Symposium. Improving the Chain of Recovery for Acute Stroke in Your Community. Task Force Reports. Held in Arlington, Virginia on December 12-13, 2002 [R] . 2003

机译：国立神经疾病与中风研讨会。改善社区急性脑卒中的恢复链。专责小组报告。于2002年12月12日至13日在弗吉尼亚州阿灵顿举行

Response to Letter Regarding Article, “Defining Clinically Relevant Cerebral Hemorrhage After Thrombolytic Therapy for Stroke: Analysis of the National Institute of Neurological Disorders and Stroke Tissue-Type Plasminogen Activator Trials”

著录项

引文网络

相似文献

相关主题

期刊订阅